ARTEC stands for ART of Engineered Cells. The company is dedicated to the development of cellular therapy products for improvement of longevity and quality of life by enhancing cellular performance with the means of genetic, cellular and tissue engineering.
The particular focus is to create a “Live cell remedy” based on immune cells with superior anti-tumor activity for cancer treatment.
Our proprietary platform is based on several patent applications and an extensive technical know-how for “off-the-shelf” cell therapy products that can be delivered for the treatment of a large number of patients.
The company is founded by Dr. Vasil Galat, who is a former Associate Professor of Pathology at Northwestern University's Feinberg School of Medicine and the Director of Human Stem Cell Unit at Stanley Manne Children’s Research Institute, Ann & Robert Lurie Children's Hospital of Chicago. The qualified team and associates provide a wide range of expertise in stem cell technology, hematopoiesis, immunology, molecular biology, genetic engineering, oncology, and human health